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PRight Ventricular Dysfunction Assessed by
Cardiovascular Magnetic Resonance Imaging
Predicts Poor Prognosis Late After Myocardial Infarction
Eric Larose, DVM, MD,* Peter Ganz, MD,* H. Glenn Reynolds, MSC,‡ Sharmila Dorbala, MD,†
Marcelo F. Di Carli, MD,† Kenneth A. Brown, MD,§ Raymond Y. Kwong, MD, MPH*
Boston, Massachusetts; and Burlington, Vermont
Objectives We sought to determine whether right ventricular (RV) function late after myocardial infarction (MI) impacts
long-term prognosis.
Background Right ventricular failure predicts early mortality in patients with acute MI. The prognostic impact of RV function
late after MI is not well defined. Accordingly, we determined whether RV dysfunction late after MI influences sur-
vival beyond traditional risk predictors, including patient age, left ventricular ejection fraction (LVEF), and infarct
size.
Methods We studied 147 consecutive patients 30 days after MI (mean age of infarct 6.7  8.2 years) who were re-
ferred for contrast-enhanced cardiovascular magnetic resonance imaging. We assessed hazard ratios for death
by RV ejection fraction (RVEF). The association of RVEF with mortality adjusted to traditional risk predictors was
examined by using multivariable Cox proportional hazards regression models.
Results A total of 26 deaths occurred during a median follow-up of 17 months (range 6 to 53 months). By univariable
analysis, RVEF 40% was strongly associated with mortality (unadjusted hazard ratio 4.02; p  0.0007). By
multivariable analysis that adjusted for patient age, left ventricular (LV) infarct size, and LVEF, RVEF 40% re-
mained a significant independent predictor of mortality (adjusted hazard ratio 2.86; p  0.03).
Conclusions Right ventricular ejection fraction quantified late after MI is an important predictor of prognosis adjusted for pa-
tient age, LV infarct size, and LVEF. Accordingly, evaluation of RVEF using cardiovascular magnetic resonance
imaging can improve risk-stratification and potentially refine patient management after MI. (J Am Coll Cardiol
2007;49:855–62) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.056t
(
r
t
c
i
p
i
p
a
s
d
M
S

a
Tatients with right ventricular (RV) dysfunction complicat-
ng acute myocardial infarction (MI) have a more than
-fold increased risk for in-hospital mortality compared
ith those without RV dysfunction (1). Nevertheless, as a
esult of the low nutrient needs of its thin wall, elaborate
ollateral circulation, and direct endocardial diffusion of
xygen (2), RV dysfunction associated with acute MI has a
igh likelihood of recovery (3,4). Whether RV dysfunction
ate after MI also portends poor prognosis remains unclear.
lthough echocardiographic assessment of tricuspid annular
xcursion (5) and radionuclide technique (6) can both assess
rom the *Cardiovascular Division, Department of Medicine, and †Department of
adiology, Brigham and Women’s Hospital and Harvard Medical School, Boston,
assachusetts; ‡General Electric Healthcare, Boston, Massachusetts; and the §Car-
iology Unit, University of Vermont College of Medicine, Burlington, the Vermont.
upported by the Brigham and Women’s Cardiovascular Magnetic Resonance
maging Fund. Dr. Larose was partly supported by Le Fonds de la Recherche en
anté du Québec (FRSQ) and the Quebec Association of Cardiologists.B
Manuscript received May 18, 2006; revised manuscript received October 3, 2006,
ccepted October 9, 2006.he RV in this setting, cardiac magnetic resonance imaging
CMR) can provide an improved quantitative and volumet-
ic method of assessing RV size and function (7–9). Fur-
hermore, late gadolinium-enhanced CMR is the current
linical standard for the assessment of left ventricular (LV)
nfarct size (10,11). Therefore, we tested the hypothesis that
ersistent RV dysfunction assessed by CMR late after MI
ncreases long-term post-MI mortality, beyond established
rognostic markers, including patient age, LV infarct size,
nd left ventricular ejection fraction (LVEF). We also
ought to identify potential underlying mechanisms of RV
ysfunction in this clinical setting.
ethods
tudy population. We enrolled 153 consecutive patients
30 days after acute MI who were referred for CMR for an
ssessment of their LV function and myocardial viability.
he Brigham and Women’s Hospital Institutional Review
oard approved the study protocol, and informed consent
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before their enrollment for
follow-up of clinical events. In
this study cohort, 78 patients
(53%) were included in a prior
report by Yan et al. (12). Myo-
cardial infarction was confirmed
by both documentation in clini-
cal records and by presence of
abnormal late gadolinium en-
hancement (LGE) on CMR
consistent with MI. Exclusion
criteria included any known clin-
ical condition that might affect
RV function independently of
the MI, including severe chronic
obstructive pulmonary disease
and interstitial lung disease, pul-
monary embolism, primary pul-
monary hypertension, congenital
heart disease, and moderate or
evere mitral or tricuspid valve diseases (either stenosis or
egurgitation). Patients with noncardiac diseases that carry
ncreased risk of mortality including renal or hepatic failure,
dvanced respiratory disease, or cancer not in complete
emission also were excluded. All patients provided a de-
ailed history at the time of CMR. Family history of
remature coronary artery disease was defined by a diagnosis
f coronary artery disease in a first-degree male relative45
ears or female 55 years. A history of dyslipidemia was
efined by fasting low-density lipoprotein cholesterol 100
g/dl or current treatment with cholesterol-lowering med-
cations. Hypertension was defined by persistent resting
ystolic blood pressure 140 mm Hg, diastolic blood
ressure 90 mm Hg, or current treatment with blood
ressure-lowering medications. Significant tobacco use was
efined as 10 pack-years of cigarette smoking. Age of MI
as defined by intervals: 3 to 6 months, 6 to 12 months, 12
o 24 months, or 24 months.
lectrocardiographic assessment. Twelve-lead electrocar-
iograms were obtained within 1 month of CMR and
nterpreted by a single experienced investigator blinded to
MR, coronary angiography, and clinical information. The
resence of MI was determined according to the Minnesota
ode (codes 1-1 through 1-2, except 1-2-8) (13,14). Un-
erlying cardiac rhythm including heart block and left
entricular hypertrophy (Sokolow-Lyon index) were re-
orded as binary variables, whereas corrected QT and QRS
nterval were recorded as continuous variables.
easure of ventricular systolic and diastolic functions
nd LV and RV infarct size by CMR. Imaging was
erformed with a 1.5-T scanner (Signa CV/i, General
lectric Healthcare, Milwaukee, Wisconsin). All acquisi-
ions were obtained with a 4- or 8-element cardiac phased-
rray surface coil with the patient supine. Electrocardio-
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
imaging
EF  ejection fraction
ESVi  indexed end-
systolic volume
HR  hazard ratio
LA  left atrium
LGE  late gadolinium
enhancement
LV  left ventricular
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
RV  right ventricular
RVEF  right ventricular
ejection fractionraphic gating and breath holding in expiration were used as wuch as feasible. After rapid cardiac localization, cine
maging of cardiac function was performed by steady-state
ree precession gradient echo technique in 8–14 parallel
hort-axis (8-mm thickness, 0-mm skip) and 3 radial
ong-axis planes. Typical cine imaging parameters included
R/TE of 3.4/1.2 ms, flip angle 45°, NEX of 1, with
n-plane spatial resolution of 1.6  2 mm, and views per
egment of 12, providing a temporal resolution of approx-
mately 40 ms. Late gadolinium-enhanced imaging of in-
arcted myocardium was acquired in matched short and
ong-axis planes using a previously validated T1-weighted
egmented inversion-recovery pulse sequence (TR/TE 4.8/
.3 ms, inversion time 200 to 300 ms to null normal
yocardium, at 10 to 15 min after the addition of 0.15
mol/kg cumulative gadolinium-diethylenetriamine penta-
cetic acid intravenously) (15,16).
Cine function analysis was performed off-line with vali-
ated software (CineTool 3.9.2, General Electric Health-
are) (17). The cardiac phase that demonstrated the largest
V cavity size was defined as end-diastole and the smallest
V cavity size as end-systole. A single experienced observer
anually traced the endocardial contours of the RV and the
V at end-diastole and -systole in all cine studies (Fig. 1).
he papillary muscles were included in the ventricular cavity
olume. If the basal slice contained both ventricular and
trial myocardium, the contours were drawn up to the
unction of the atrium and the ventricle and joined by a
traight line through the blood pool. The RV and LV
nd-diastolic and -systolic volumes and the ejection fraction
EF) were computed using the Simpson’s rule. Right and
eft ventricular volumes were adjusted to body surface area
y using the Dubois Formula (18) to yield the respective
olume indices. In the basal slice, both in end-diastole and
systole, if the pulmonary valve was visible, only the portion
f the volume surrounded by trabeculated myocardium
elow the level of the pulmonary valve was included. For the
nflow portion of the RV, the blood volume was excluded
rom the RV volume if the surrounding wall was thin and
ot trabeculated, as it was considered to be in the right
trium.
To reflect common practice in the clinical setting, LVEF
nd RVEF were recorded as continuous variables and also
ichotomized as “normal” or “abnormal.” Abnormal RVEF
as defined as 40% based on a mean  3 SD of reported
ge-adjusted normal using the steady-state free precession
ine technique (19,20). The location and size of LV and RV
nfarct were determined by LGE imaging. Infarcted myo-
ardium was quantitated by semiautomatic detection of any
egion with signal intensity 2 SD above the mean signal
ntensity of the remote myocardium as previously validated
21). Left ventricular infarct size was reported in grams as
ell as calculated as a percent of total LV mass. Right
entricular LGE consistent with RV infarction was identi-
ed by a consensus agreement among 2 cardiologists who
ere experienced in CMR interpretation and blinded to
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February 27, 2007:855–62 RV Dysfunction by CMR and Post-MI MortalityVEF, LVEF, and clinical outcome. Infarct size in the RV
as assessed by the number of infarcted segments on a
-segment model described by Tandri et al. (22). Left atrial
imension represents a preload independent marker of LV
iastolic function and provides prognostic information in
opulation-based studies (23). The left atrial size was
easured at mid-anterior-posterior dimension from the
-chamber cine imaging view at end-ventricular systole.
oronary angiography. Coronary angiography was per-
ormed in 65 patients within 6 months of CMR per
iscretion of the attending physicians. An experienced
nvestigator blinded to CMR findings and clinical events
ssessed the presence of coronary stenoses in 2 orthogonal
iews of each BARI-defined segment by quantitative coro-
ary angiography using validated software (CMS-QCA,
Figure 1 Example of Volumetric Determination of RV and LV Ej
Endocardial borders are delineated manually for right ventricular (RV) (RVEN, yellow
to apex to determine cavity areas at end-systole and -diastole (end-diastole shown
and -diastolic volumes and calculate ejection fraction. In this example, an RV ejec
cle endocardial border; LVEP  left ventricle epicardial border; RVEN  right ventredis, the Netherlands) (24). Significant stenoses were aefined as70% luminal narrowing in the most severe view
50% for left main stenosis).
ollow-up. After CMR, subjects were prospectively fol-
owed for a median of 17 months (range 6 to 53 months).
linical follow-up based on a standard questionnaire was
btained from telephone interviews with the patients or
elatives, physicians, or from hospital records. Survival
tatus was obtained through a query of the National Social
ecurity Death Index (25).
tatistical analysis. Baseline patient characteristics strati-
ed by RVEF are displayed in Table 1. Two-tailed t test
nd Fisher exact test were used as appropriate. We fitted
ox proportional-hazards survival models to estimate un-
djusted hazard ratios (HRs) and the 95% confidence
ntervals of all the variables. We performed 2 multivariable
n Fraction
and left ventricular (LV) (LVEN, red line) every 8 mm from atrioventricular valve
. Consecutive areas are summed by Simpson’s method to calculate end-systolic
ction was measured at 35% and LV ejection fraction at 61%. LVEN  left ventri-
icardial border.ectio
line)
here)
tion fra
icle epnalyses to assess for any incremental prognostic value of
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RV Dysfunction by CMR and Post-MI Mortality February 27, 2007:855–62V dysfunction for all-cause mortality late after MI in
ddition to known prognostic markers. First, we aimed to
uild the best-overall parsimonious model for mortality late
fter MI. We performed stepwise forward selection consider-
ng any clinical or imaging variables listed in Tables 1 and 2.
ignificant levels of covariate entry or stay were both set
t p  0.05. Second, we assessed the association of RVEF
40% to mortality adjusted to known post-MI predic-
ors, including patient age, LV infarct size (per 10% LV
ass), and LVEF (per 10% LVEF). The validity of the
roportional-hazards assumption was tested by adding a
ime-dependent interaction variable to each of the final
odels for each of the predictors in the models. All
redictors in the final models fulfilled the validity of the
Demographic Characteristics of the Study Popu
Table 1 Demographic Characteristics of the
Overall
(n  147)
Age, yrs 63 11
Male gender, % 78
Diabetes, % 37
Hypertension, % 63
Dyslipidemia, % 89
Smoking, % 33
Family history premature CAD, % 33
History of prior PCI, % 41
History of prior CABG, % 37
Revascularization after CMR 37
Infarct location by DE, %
LAD territory 33
RCA territory 43
LCx territory 8
Mixed territories 17
ASA therapy, % 90
Statin therapy, % 85
Beta-blocker therapy, % 81
ACE inhibitor therapy, % 64
Calcium channel blocker therapy, % 10
ACE  angiotensin-converting enzyme; ASA  acetylsalicylic acid; CA
cardiovascular magnetic resonance; DE  delayed enhancement; LA
coronary intervention; RCA  right coronary artery; RVEF  right vent
Electrocardiographic Features of the Study Popu
Table 2 Electrocardiographic Features of th
Overall
(n  147
Normal sinus rhythm, % 97
Resting heart rate 100 beats/min, % 3
Left ventricular hypertrophy, % 6
Significant Q waves, % 36
Prolonged QRS 200 ms, % 22
Left bundle branch block, % 13
Right bundle branch block, % 7
Prolonged corrected QT 440 ms, % 43
ST-segment depression, % 23
T-wave inversion, % 33
Any ECG abnormality, % 81ECG  electrocardiogram; RVEF  right ventricular ejection fraction.roportional-hazards assumption. Spearman correlation
ssessed the relationship of RVEF to parameters of LV
unction (LV indexed end-systolic volume [ESVi],
VEF, and left atrial size). Analyses were performed using
AS version 9.1 (SAS Institute, Cary, North Carolina).
esults
e enrolled 153 consecutive subjects 30 days after MI
eferred for CMR assessment of ventricular function and
yocardial viability. Assessment of vital status was complete
n all patients. Six patients were excluded from further
nalysis because of severe mitral regurgitation (n  3) or
oor image quality (n  3). All 6 patients were alive at the
y Population
RVEF >40%
(n  122)
RVEF <40%
(n  25) p Value
63 10 64 12 NS
77 84 NS
34 48 NS
66 52 NS
90 84 NS
32 36 NS
34 28 NS
43 32 NS
39 28 NS
29 8 NS
31 40 NS
43 44 NS
9 0 NS
17 16 NS
91 88 NS
87 73 NS
87 52 0.002
65 60 NS
12 0 NS
oronary artery bypass graft; CAD  coronary artery disease; CMR 
ft anterior descending; LCx  left circumflex; PCI  percutaneous
jection fraction.
n
dy Population
RVEF >40%
(n  122)
RVEF <40%
(n  25) p Value
98 91 NS
2 8 NS
7 0 NS
32 59 0.03
21 27 NS
12 18 NS
6 9 NS
43 41 NS
23 23 NS
33 36 NS
79 91 NSlation
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February 27, 2007:855–62 RV Dysfunction by CMR and Post-MI Mortalitynd of study follow-up. The remaining 147 patients (115
en, mean age 63  11 years) constituted the study cohort.
ean interval between MI and CMR study was 6.7  8.2
ears (10%: 3 to 6 months, 3%: 6 to 12 months, 8%: 12 to
4 months, and 79%: 24 months after MI). Twenty-six
atients died after a median follow-up of 17 months (range
to 53 months). Univariable associations with post-MI
ortality are presented in Table 3. Kaplan-Meier analysis
emonstrated that RVEF 40% was associated with a
arkedly reduced survival (p  0.0001) (Fig. 2). Within 6
onths of the CMR study, significant angiographic coro-
ary stenosis (70% diameter stenosis by quantitative
Unadjusted Analysis of Hazard Ratio for All-Caus
Table 3 Unadjusted Analysis of Hazard Ratio
Hazard
(
Age, yrs
Female gender
History of PCI
History of CABG
History of hypertension
History of diabetes
History of hypercholesterolemia
History of smoking
Family history of CAD
Aspirin use
Statin use
Beta-blocker use
ACE inhibitor use
Resting tachycardia (rate 100 beats/min)
Nonsinus rhythm
LVH on ECG
QRS 200 ms
LBBB
RBBB
Corrected QT 420 ms
Q wave
ST-segment depression
T-wave inversion
70% coronary stenosis of RCA
70% coronary stenosis of any vessel
LVEF (per 10%)
LVESVi (per 10 ml/m3)
LVEDVi (per 10 ml/m2)
LA size (per mm)
LV mass (per every 10 g)
LV infarct size (per 10% of LV mass)
LV infarct size (per every 10 g)
RVEF 40%
RVEF (per 10% decrease)
RVESVi (per 10 ml/m3)
RVEDVi (per 10 ml/m2)
RV infarct (presence or absence)
RV infarct size (per number of segments)
ACE angiotensin-converting enzyme; CABG coronary artery bypass
atrium; LBBB  left bundle-branch block; LV  left ventricular; LVEDVi
LVESVi indexed LV end-systolic volume; LVH left ventricular hypertr
block; RCA  right coronary artery; RV  right ventricular; RVEDVi  indexed
RVESVi  indexed right systolic volume.oronary angiography) was noted in 57 (39%) of subjects,
ncluding significant RCA stenosis in 39 patients (27%).
ndices of RV and LV function of the cohort are reported in
able 4. Right ventricular ejection fraction (per each 10%
ecrease) and RVEF 40% (by dichotomous analysis)
emonstrated a strong association with mortality (unad-
usted HR 1.45, p  0.005 and 4.02, p  0.0007, respec-
ively) (Table 3). Although LVEF also was significantly
ssociated with mortality late after MI, LV infarct size (by
ram or % LV mass) was not (Table 4). Other significant
nivariate predictors of mortality included corrected QT,
eft atrium (LA) size, resting tachycardia, and nonsinus
rtality
All-Cause Mortality
for Death
6) 95% Confidence Interval p Value
0.62 to 1.3 NS
0.77 to 4.16 NS
0.20 to 1.13 0.09
0.49 to 2.64 NS
0.32 to 1.54 NS
0.47 to 2.55 NS
0.22 to 4.06 NS
0.81 to 4.09 NS
0.58 to 2.94 NS
0.24 to 4.44 NS
0.30 to 3.31 NS
0.23 to 1.16 0.11
0.33 to 1.62 NS
1.67 to 32.2 0.008
1.50 to 16.9 0.009
0.1 to 5.56 NS
0.46 to 2.96 NS
0.44 to 3.79 NS
0.50 to 5.75 NS
1.08 to 5.63 0.03
0.32 to 1.75 NS
0.35 to 2.48 NS
0.19 to 1.34 NS
0.86 to 4.19 0.11
0.55 to 2.67 NS
0.60 to 0.98 0.03
0.97 to 1.14 NS
0.95 to 1.13 NS
1.04 to 1.15 0.0009
0.99 to 1.19 0.07
0.79 to 1.34 NS
0.89 to 1.26 NS
1.80 to 8.96 0.0007
1.12 to 1.85 0.005
0.96 to 1.34 NS
0.85 to 1.23 NS
0.82 to 7.23 0.11
1.17 to 2.04 0.003
g; CAD coronary artery disease; ECG electrocardiogram; LA left
xed LV end-diastolic volume; LVEF  left ventricular ejection fraction;
CI percutaneous coronary intervention; RBBB right bundle-branche Mo
for
Ratio
n  2
0.90
1.79
0.47
1.14
0.70
1.09
0.95
1.82
1.3
1.04
0.99
0.51
0.72
7.34
5.03
0.75
1.17
1.29
1.70
2.47
0.74
0.93
0.5
1.9
1.21
0.77
1.05
1.03
1.09
1.09
1.03
1.06
4.02
1.45
1.14
1.02
2.44
1.54
graftin
 inde
ophy; PRV end-diastolic volume; RVEF  right ventricular ejection fraction;
r
e

I
a
d
O
L
a
i
r
t
t
T
a
i
c
m
o
L
i
a
d
p
t
e
0
D
T
d
R
t
t
c
i
i
d
p
M
C
f
s
a
d
i
H
r
d
i
s
i
h
f
R
t
c
t
a
a
CI
W
M
L
f
860 Larose et al. JACC Vol. 49, No. 8, 2007
RV Dysfunction by CMR and Post-MI Mortality February 27, 2007:855–62hythm. Right ventricular ejection fraction correlated mod-
stly with LVEF (r  0.39, p  0.0001), LVESVi (r 
0.37, p  0.0001), and LA size (r  0.17, p  0.05).
mage quality of LGE imaging was adequate and allowed
ssessment of RV MI in 144 subjects, among them 13
emonstrated LGE of the RV consistent with RV MI.
nly 4 patients with RVEF40% demonstrated RV MI by
GE imaging (p  NS). Univariable analysis revealed that
lthough the size of RV MI (by number of RV segments
nvolved) was associated with post-MI mortality (hazard
atio 1.54, 95% confidence interval 1.17 to 2.04, p 0.003),
he presence of RV MI did not significantly predict mor-
ality (HR 2.44, p  0.11).
Results of the multivariable analyses are presented in
able 5. In the first multivariable approach, RVEF 40%
nd left atrial enlargement were the only variables selected
n forming the best overall model for mortality in this study
ohort. In the second multivariable approach, RVEF 40%
aintained strong association with mortality, independent
f patient age, LV infarct size, and LVEF (per 10% of
VEF) combined. After adjusting for patient age, LV
nfarct size, and LVEF, RVEF40% incurred a near 3-fold
Figure 2 Kaplan-Meier Survival of Study
Cohort Stratified by RVEF of 40%
RVEF  right ventricular ejection fraction.
ardiovascular Magnetic Resonancemaging Measurements of the Study Population
Table 4 Cardiovascular Magnetic ResonanceImaging Measurements of the Study Population
Overall
(n  147)
RVEF >40%
(n  122)
RVEF <40%
(n  25) p Value
LVEF, % 45 17 47 16 32 14 0.0001
LVESVi, ml/m2 65 41 59 39 94 42 0.0001
LVEDVi, ml/m2 109 39 104 37 133 37 0.001
RVEF, % 52 13 56 8 31 11 0.0001
RVESVi, ml/m2 34 18 29 11 60 27 0.0001
RVEDVi, ml/m2 68 22 65 19 85 30 0.0001
LV mass, g 147 43 148 44 142 37 NS
Any WMA, % 90 88 100 NS
LV infarct size, g 22 21 21 21 27 26 NS
LV infarct size, %LV mass 16 15 15 15 19 19 NS
Left atrial size, mm 42 7 42 8 45 7 0.07gMA  wall motion abnormality; other abbreviations as in Table 3.djusted hazard increase for mortality. Age of MI only
emonstrated a trend association with mortality (HR 2.21,
 0.07). Right ventricular ejection fraction 40% main-
ained a significant association with mortality adjusted to
ither RV infarct size or age of MI (adjusted HR 3.47, p 
.004, and HR 3.34, p  0.004, respectively).
iscussion
his study evaluated the prognostic implications of RV
ysfunction late after MI, using volumetric quantification of
VEF by cine CMR. Our data indicate that RV dysfunc-
ion late after MI is the strongest multivariable predictor in
he best overall model of post-MI mortality in our study
ohort. In particular, RVEF 40% carries almost a 3-fold
ncrease in mortality, after adjusting for patient age, LV
nfarct size, and LVEF. We also conclude that RV global
ysfunction in this clinical setting likely reflects several
ossible mechanisms and cannot be accounted for by RV
I alone.
ontroversies surrounding the prognostic weight of RV
unction. Right ventricular dysfunction has long been as-
ociated with in-hospital morbidity and mortality early after
cute MI (26). Mehta et al. (27) demonstrated that RV
ysfunction at the time of MI increases 6-month mortality
ndependently of the extent of LV myocardial damage.
owever, most RV dysfunction during the acute phase
esolves, and it remains controversial as to whether RV
ysfunction identified outside the acute setting of MI
ndependently predicts poor prognosis (2,28–31). Although
ome argued that dysfunction of the afterload-sensitive RV
s merely a reflection of LV failure (32,33), Kaul et al. (34)
ave suggested that the effects of previous MI on RV
unction depend little on the extent of LV dysfunction.
ole of CMR in RV function analysis. Compared with
he LV, RV volume and RVEF quantification have been
hallenged by a complex geometric shape and RV wall
hickness of mere 3 to 4 mm. Although echocardiography
nd nuclear medicine technique are valuable clinical tools in
ssessing global RV function and stratifying patient risk,
ultivariable Associations With All-Cause Mortality
Table 5 Multivariable Associations With All-Cause Mortality
Hazard Ratio
(95% Confidence Interval) p Value
Best overall multivariable model
Left atrial size, mm 1.07 (1.02–1.13) 0.007
RVEF 40% 3.54 (1.50–8.36) 0.004
Association of RVEF 40% adjusted
for patient age, LV infarct size,
and LVEF
Patient age, yrs 0.85 (0.58–1.25) 0.41
LV infarct size (per 10% of LV mass) 0.91 (0.68–1.21) 0.50
LVEF (per 10% change) 0.82 (0.61–1.012) 0.21
RVEF 40% 2.86 (1.13–7.25) 0.03
V  left ventricular; LVEF  left ventricular ejection fraction; RVEF  right ventricular ejection
raction.eometric assumptions in modeling the complex RV shape
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February 27, 2007:855–62 RV Dysfunction by CMR and Post-MI Mortalityestricts the ability of these techniques in accurate and
recise quantification of RV function. As a result, a wide
ange of “normal” values for RVEF has been reported by
chocardiographic techniques (5,6,35,36). With tomo-
raphic scan planes, and high spatial and temporal resolu-
ion, CMR is the recognized clinical reference tool for RV
tructure and function in a spectrum of cardiac diseases
nvolving the RV (7–9,37).
ndependent impact of RV function on survival and the
otential mechanisms of RV dysfunction. The prognostic
ignificance of reduced LVEF has been investigated exten-
ively in subjects with a history of clinical MI (38). Al-
hough we observed that LV infarct size demonstrated
ignificant inverse correlation with LVEF (r  0.49, p 
.0001) as reported in previous studies (39), LV infarct size
er se was not associated with all-cause mortality (p  NS).
lthough this lack of association may reflect the heteroge-
eous chronicity of MI of the study population or limited
tudy power owing to the relatively small sample size,
yriad neurohormonal factors beyond LV infarct size have
een described that can mediate ventricular remodeling,
rrhythmias, and impact on post-MI clinical outcomes (40).
mportant prognostic factors such as the presence and
xtent of myocardial hibernation and stunning may not be
eflected by LV infarct size alone. Therefore, consistent
ith previous studies, we found that LVEF was a stronger
redictor of all-cause mortality than was LV infarct size
HR 0.77, p  0.03 vs. HR 1.06, p  NS, respectively)
41). Although LVEF predicts long-term mortality after
I, it does so only modestly and hence other factors that
levate risk of cardiac death late after MI need to be defined
42). Our study identified one such powerful factor, RVEF
40%, heralding increased mortality late after MI. Early
fter an acute MI, decreased RVEF may occur without
mpaired LVEF in inferior MI whereas decreased RVEF
nly occurs with impaired LVEF in anterior MI, suggesting
hat RV failure is associated with RV ischemia in inferior
I and overload in anterior MI (43). Later after MI,
mpaired RV function likely reflects a manifestation of
ommon conditions, including RV infarction or ischemia,
ulmonary hypertension secondary to LV dysfunction, or
ubclinical pulmonary thromboembolic disease. Our obser-
ation that only 16% of subjects with RV dysfunction late
fter MI actually have RV necrosis identified by LGE
uggests that RV MI is not the sole mechanism underlying
V dysfunction in this setting. Although we noticed that
VEF was related to indices of LV function (LVEF,
VESVi, and LA dimension), the finding that RVEF
aintained strong adjusted association with post-MI mor-
ality beyond the indices of LV function may have impor-
ant clinical implications. This may reflect the presence of
ther subclinical conditions, such as RV ischemia without
nfarction or pulmonary disease that affect RV function and
ave negative impact on patient prognosis.
tudy limitations. The current study has several limita-ions. Although CMR is the best current standard foruantitation of RV function, it could be difficult to discrim-
nate the RV from atrium at the level of the tricuspid valve
n short-axis because of the dynamic through-plane motion
f the atrioventricular groove during the cardiac cycle. This
echnical consideration was accounted for in our study by
areful observation of the tricuspid valve and heart chambers
n motion before obtaining measurements, coupled with the
dentification of atrium as the thinner-walled chamber
evoid of trabeculations. Variability in RV measurements
as reduced by relying on a single experienced operator to
erform all measurements. Measurement of pulmonary
rterial pressure by echocardiographic Doppler technique at
he same time of the CMR could have contributed to
xplaining the mechanisms of RV dysfunction but were not
vailable in most patients in this cohort. We did, however,
valuate for RV infarction by LGE and assessed the
elationship of RVEF with indices of LV function, to
urther explore the mechanisms underlying RV dysfunction
n this clinical setting. It should be emphasized that al-
hough volumetric CMR technique can quantify RVEF at
igh accuracy and reproducibility, RVEF is load-dependent
nd does not fully represent RV myocardial performance.
iven the small sample size of this study cohort, the current
ndings should be replicated in a larger population.
onclusions
his study demonstrates that RV function assessed late after
linical MI is an important predictor of post-MI mortality,
ndependent of patient age, LV infarct size, and LVEF.
valuation of RV function using CMR may improve the
isk stratification of patients with MI beyond current
ractice and refine their medical management.
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